A delay in diagnosis can have lasting consequences1

Discover diagnostic tools

hATTR has broad-ranging and seemingly unrelated symptoms1,2

Connect the symptoms of hATTR

Hero-BgHero-Bg

Hereditary transthyretin-mediated amyloidosis (hATTR) is a systemic disease with a constellation of clinical manifestations1

SEE THE PATTRNS.

TAKE ACTION TO DIAGNOSE AND MANAGE hATTR.

A delay in diagnosis can have lasting consequences1

Discover diagnostic tools

hATTR has broad-ranging and seemingly unrelated symptoms1,2

Connect the symptoms of hATTR

References: 1. Nativi-Nicolau JN, Karam C, Khella S, Maurer MS. Screening for ATTR amyloidosis in the clinic: overlapping disorders, misdiagnosis, and multiorgan awareness. Heart Fail Rev. 2022;27(3):785-793. 2. Gertz M, Adams D, Ando Y, et al. Avoiding misdiagnosis: expert consensus recommendations for the suspicion and diagnosis of transthyretin amyloidosis for the general practitioner. BMC Fam Pract. 2020;21(1):198.

Back to top